CCL2 and systemic sclerosis: In contrast, incubation with 0.4 μg/mL SN38 during 24 h significantly increased mRNA expression of CCL2 (+ 163.8 ± 49.6, p = 0.04, paired t-test) in dermal fibroblasts of SSc patients treated with SN38 vs. the non-treated condition.